RacotumomabRacotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by ReComBio (R and Research in Computational Biology), an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba… Read from the Drugbox of the Wikipedia article Racotumomab, revision 1314785246.

Property

Value

Formula

C6476H9922N1712O2048S50, 146131.81 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.